<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-05-02" modified="2020-10-07" version="196">
<accession>Q9Y572</accession>
<accession>B4DJL9</accession>
<accession>C4AM87</accession>
<accession>Q5J795</accession>
<accession>Q5J796</accession>
<accession>Q6P5Y1</accession>
<name>RIPK3_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="24">Receptor-interacting serine/threonine-protein kinase 3</fullName>
<ecNumber evidence="12 15">2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="21">RIP-like protein kinase 3</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="21">Receptor-interacting protein 3</fullName>
<shortName evidence="21">RIP-3</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="30">RIPK3</name>
<name type="synonym" evidence="21">RIP3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Curr. Biol." volume="9" first="539" last="542">
<title>Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB.</title>
<authorList>
<person name="Yu P.W."/>
<person name="Huang B.C.B."/>
<person name="Shen M."/>
<person name="Quast J."/>
<person name="Chan E."/>
<person name="Xu X."/>
<person name="Nolan G.P."/>
<person name="Payan D.G."/>
<person name="Luo Y."/>
</authorList>
<dbReference type="PubMed" id="10339433"/>
<dbReference type="DOI" id="10.1016/s0960-9822(99)80239-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF LYS-50</scope>
<scope>INTERACTION WITH RIPK1</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Lymphocyte</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="16871" last="16875">
<title>RIP3, a novel apoptosis-inducing kinase.</title>
<authorList>
<person name="Sun X."/>
<person name="Lee J."/>
<person name="Navas T."/>
<person name="Baldwin D.T."/>
<person name="Stewart T.A."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="10358032"/>
<dbReference type="DOI" id="10.1074/jbc.274.24.16871"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF LYS-50</scope>
<source>
<tissue>Aortic endothelium</tissue>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="332" first="181" last="187">
<title>RIP3 beta and RIP3 gamma, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis.</title>
<authorList>
<person name="Yang Y."/>
<person name="Hu W."/>
<person name="Feng S."/>
<person name="Ma J."/>
<person name="Wu M."/>
</authorList>
<dbReference type="PubMed" id="15896315"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.04.114"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Nature" volume="421" first="601" last="607">
<title>The DNA sequence and analysis of human chromosome 14.</title>
<authorList>
<person name="Heilig R."/>
<person name="Eckenberg R."/>
<person name="Petit J.-L."/>
<person name="Fonknechten N."/>
<person name="Da Silva C."/>
<person name="Cattolico L."/>
<person name="Levy M."/>
<person name="Barbe V."/>
<person name="De Berardinis V."/>
<person name="Ureta-Vidal A."/>
<person name="Pelletier E."/>
<person name="Vico V."/>
<person name="Anthouard V."/>
<person name="Rowen L."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Sun H."/>
<person name="Du H."/>
<person name="Pepin K."/>
<person name="Artiguenave F."/>
<person name="Robert C."/>
<person name="Cruaud C."/>
<person name="Bruels T."/>
<person name="Jaillon O."/>
<person name="Friedlander L."/>
<person name="Samson G."/>
<person name="Brottier P."/>
<person name="Cure S."/>
<person name="Segurens B."/>
<person name="Aniere F."/>
<person name="Samain S."/>
<person name="Crespeau H."/>
<person name="Abbasi N."/>
<person name="Aiach N."/>
<person name="Boscus D."/>
<person name="Dickhoff R."/>
<person name="Dors M."/>
<person name="Dubois I."/>
<person name="Friedman C."/>
<person name="Gouyvenoux M."/>
<person name="James R."/>
<person name="Madan A."/>
<person name="Mairey-Estrada B."/>
<person name="Mangenot S."/>
<person name="Martins N."/>
<person name="Menard M."/>
<person name="Oztas S."/>
<person name="Ratcliffe A."/>
<person name="Shaffer T."/>
<person name="Trask B."/>
<person name="Vacherie B."/>
<person name="Bellemere C."/>
<person name="Belser C."/>
<person name="Besnard-Gonnet M."/>
<person name="Bartol-Mavel D."/>
<person name="Boutard M."/>
<person name="Briez-Silla S."/>
<person name="Combette S."/>
<person name="Dufosse-Laurent V."/>
<person name="Ferron C."/>
<person name="Lechaplais C."/>
<person name="Louesse C."/>
<person name="Muselet D."/>
<person name="Magdelenat G."/>
<person name="Pateau E."/>
<person name="Petit E."/>
<person name="Sirvain-Trukniewicz P."/>
<person name="Trybou A."/>
<person name="Vega-Czarny N."/>
<person name="Bataille E."/>
<person name="Bluet E."/>
<person name="Bordelais I."/>
<person name="Dubois M."/>
<person name="Dumont C."/>
<person name="Guerin T."/>
<person name="Haffray S."/>
<person name="Hammadi R."/>
<person name="Muanga J."/>
<person name="Pellouin V."/>
<person name="Robert D."/>
<person name="Wunderle E."/>
<person name="Gauguet G."/>
<person name="Roy A."/>
<person name="Sainte-Marthe L."/>
<person name="Verdier J."/>
<person name="Verdier-Discala C."/>
<person name="Hillier L.W."/>
<person name="Fulton L."/>
<person name="McPherson J."/>
<person name="Matsuda F."/>
<person name="Wilson R."/>
<person name="Scarpelli C."/>
<person name="Gyapay G."/>
<person name="Wincker P."/>
<person name="Saurin W."/>
<person name="Quetier F."/>
<person name="Waterston R."/>
<person name="Hood L."/>
<person name="Weissenbach J."/>
</authorList>
<dbReference type="PubMed" id="12508121"/>
<dbReference type="DOI" id="10.1038/nature01348"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Thalamus</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="9505" last="9511">
<title>Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3.</title>
<authorList>
<person name="Sun X."/>
<person name="Yin J."/>
<person name="Starovasnik M.A."/>
<person name="Fairbrother W.J."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="11734559"/>
<dbReference type="DOI" id="10.1074/jbc.m109488200"/>
</citation>
<scope>RIP HOMOTYPIC INTERACTION MOTIF</scope>
<scope>PHOSPHORYLATION AT SER-199</scope>
<scope>INTERACTION WITH RIPK1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Science" volume="325" first="332" last="336">
<title>RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis.</title>
<authorList>
<person name="Zhang D.W."/>
<person name="Shao J."/>
<person name="Lin J."/>
<person name="Zhang N."/>
<person name="Lu B.J."/>
<person name="Lin S.C."/>
<person name="Dong M.Q."/>
<person name="Han J."/>
</authorList>
<dbReference type="PubMed" id="19498109"/>
<dbReference type="DOI" id="10.1126/science.1172308"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PYGL; GLUL AND GLUD1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Cell" volume="137" first="1100" last="1111">
<title>Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.</title>
<authorList>
<person name="He S."/>
<person name="Wang L."/>
<person name="Miao L."/>
<person name="Wang T."/>
<person name="Du F."/>
<person name="Zhao L."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="19524512"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.05.021"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-199</scope>
<scope>INTERACTION WITH RIPK1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Cell" volume="137" first="1112" last="1123">
<title>Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.</title>
<authorList>
<person name="Cho Y.S."/>
<person name="Challa S."/>
<person name="Moquin D."/>
<person name="Genga R."/>
<person name="Ray T.D."/>
<person name="Guildford M."/>
<person name="Chan F.K."/>
</authorList>
<dbReference type="PubMed" id="19524513"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.05.037"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RE4" last="RE4">
<title>The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.</title>
<authorList>
<person name="Vandenabeele P."/>
<person name="Declercq W."/>
<person name="Van Herreweghe F."/>
<person name="Vanden Berghe T."/>
</authorList>
<dbReference type="PubMed" id="20354226"/>
<dbReference type="DOI" id="10.1126/scisignal.3115re4"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E22356" last="E22356">
<title>cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4).</title>
<authorList>
<person name="Bertrand M.J."/>
<person name="Lippens S."/>
<person name="Staes A."/>
<person name="Gilbert B."/>
<person name="Roelandt R."/>
<person name="De Medts J."/>
<person name="Gevaert K."/>
<person name="Declercq W."/>
<person name="Vandenabeele P."/>
</authorList>
<dbReference type="PubMed" id="21931591"/>
<dbReference type="DOI" id="10.1371/journal.pone.0022356"/>
</citation>
<scope>UBIQUITINATION BY BIRC2/C-IAP1 AND BIRC3/C-IAP2</scope>
<scope>INTERACTION WITH BIRC2/C-IAP1; BIRC3/C-IAP2 AND XIAP/BIRC4</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2012" name="Cell" volume="148" first="213" last="227">
<title>Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.</title>
<authorList>
<person name="Sun L."/>
<person name="Wang H."/>
<person name="Wang Z."/>
<person name="He S."/>
<person name="Chen S."/>
<person name="Liao D."/>
<person name="Wang L."/>
<person name="Yan J."/>
<person name="Liu W."/>
<person name="Lei X."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="22265413"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.11.031"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH MLKL</scope>
<scope>PHOSPHORYLATION AT SER-227</scope>
<scope>ACTIVE SITE</scope>
<scope>MUTAGENESIS OF ASP-142 AND SER-227</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2012" name="Cell" volume="148" first="228" last="243">
<title>The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways.</title>
<authorList>
<person name="Wang Z."/>
<person name="Jiang H."/>
<person name="Chen S."/>
<person name="Du F."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="22265414"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.11.030"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN COMPLEX WITH PGAM5; RIPK1 AND MLKL</scope>
<scope>MUTAGENESIS OF LYS-50</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="Inflamm. Bowel Dis." volume="18" first="603" last="612">
<title>Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Alonso C."/>
<person name="Ballester I."/>
<person name="Song J.H."/>
<person name="Chang S.Y."/>
<person name="Guleng B."/>
<person name="Arihiro S."/>
<person name="Murray P.J."/>
<person name="Xavier R."/>
<person name="Kobayashi K.S."/>
<person name="Reinecker H.C."/>
</authorList>
<dbReference type="PubMed" id="21887730"/>
<dbReference type="DOI" id="10.1002/ibd.21851"/>
</citation>
<scope>INTERACTION WITH ARHGEF2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="5322" last="5327">
<title>Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis.</title>
<authorList>
<person name="Zhao J."/>
<person name="Jitkaew S."/>
<person name="Cai Z."/>
<person name="Choksi S."/>
<person name="Li Q."/>
<person name="Luo J."/>
<person name="Liu Z.G."/>
</authorList>
<dbReference type="PubMed" id="22421439"/>
<dbReference type="DOI" id="10.1073/pnas.1200012109"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MLKL</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="15438" last="15443">
<title>Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense.</title>
<authorList>
<person name="Wang X."/>
<person name="Li Y."/>
<person name="Liu S."/>
<person name="Yu X."/>
<person name="Li L."/>
<person name="Shi C."/>
<person name="He W."/>
<person name="Li J."/>
<person name="Xu L."/>
<person name="Hu Z."/>
<person name="Yu L."/>
<person name="Yang Z."/>
<person name="Chen Q."/>
<person name="Ge L."/>
<person name="Zhang Z."/>
<person name="Zhou B."/>
<person name="Jiang X."/>
<person name="Chen S."/>
<person name="He S."/>
</authorList>
<dbReference type="PubMed" id="25316792"/>
<dbReference type="DOI" id="10.1073/pnas.1412767111"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HUMAN HERPESVIRUS PROTEIN 1 RIR1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2018" name="Mol. Cell" volume="70" first="920" last="935">
<title>PELI1 selectively targets kinase-active RIP3 for ubiquitylation-dependent proteasomal degradation.</title>
<authorList>
<person name="Choi S.W."/>
<person name="Park H.H."/>
<person name="Kim S."/>
<person name="Chung J.M."/>
<person name="Noh H.J."/>
<person name="Kim S.K."/>
<person name="Song H.K."/>
<person name="Lee C.W."/>
<person name="Morgan M.J."/>
<person name="Kang H.C."/>
<person name="Kim Y.S."/>
</authorList>
<dbReference type="PubMed" id="29883609"/>
<dbReference type="DOI" id="10.1016/j.molcel.2018.05.016"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION AT LYS-363</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
<scope>MUTAGENESIS OF LYS-50; THR-182; TYR-185; SER-227 AND LYS-363</scope>
<scope>INTERACTION WITH PELI1; STUB1; RIPK1; TRAF2; MLKL AND BUB1B</scope>
<scope>PHOSPHORYLATION AT THR-182 AND SER-227</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] MET-300 AND GLN-492</scope>
</reference>
<reference key="21" evidence="1 2">
<citation type="journal article" date="2018" name="Cell" volume="173" first="1244" last="1253">
<title>The structure of the necrosome RIPK1-RIPK3 core, a human hetero-amyloid signaling complex.</title>
<authorList>
<person name="Mompean M."/>
<person name="Li W."/>
<person name="Li J."/>
<person name="Laage S."/>
<person name="Siemer A.B."/>
<person name="Bozkurt G."/>
<person name="Wu H."/>
<person name="McDermott A.E."/>
</authorList>
<dbReference type="PubMed" id="29681455"/>
<dbReference type="DOI" id="10.1016/j.cell.2018.03.032"/>
</citation>
<scope>STRUCTURE BY NMR OF 448-462 IN COMPLEX WITH RIPK1</scope>
<scope>X-RAY CRYSTALLOGRAPHY (1.27 ANGSTROMS) OF 458-461 IN COMPLEX WITH RIPK1</scope>
<scope>INTERACTION WITH RIPK1</scope>
<scope>DOMAIN</scope>
</reference>
<comment type="function">
<text evidence="3 10 11 12 15 16 17 18 20">Serine/threonine-protein kinase that activates necroptosis and apoptosis, two parallel forms of cell death (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:29883609). Necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members, is triggered by RIPK3 following activation by ZBP1 (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:29883609). Activated RIPK3 forms a necrosis-inducing complex and mediates phosphorylation of MLKL, promoting MLKL localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:25316792, PubMed:29883609). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (By similarity). Also regulates apoptosis: apoptosis depends on RIPK1, FADD and CASP8, and is independent of MLKL and RIPK3 kinase activity (By similarity). Phosphorylates RIPK1: RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation (PubMed:19524513). In some cell types, also able to restrict viral replication by promoting cell death-independent responses (By similarity). In response to Zika virus infection in neurons, promotes a cell death-independent pathway that restricts viral replication: together with ZBP1, promotes a death-independent transcriptional program that modifies the cellular metabolism via up-regulation expression of the enzyme ACOD1/IRG1 and production of the metabolite itaconate (By similarity). Itaconate inhibits the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes (By similarity). RIPK3 binds to and enhances the activity of three metabolic enzymes: GLUL, GLUD1, and PYGL (PubMed:19498109). These metabolic enzymes may eventually stimulate the tricarboxylic acid cycle and oxidative phosphorylation, which could result in enhanced ROS production (PubMed:19498109).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 15">
<text>ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]</text>
<dbReference type="Rhea" id="RHEA:17989"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 15">
<text>ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:46608"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="3">Activity is stimulated by ZBP1, which senses double-stranded Z-RNA structures (By similarity). RIPK3-dependent necroptosis is inhibited by RIPK1: RIPK1 prevents the ZBP1-induced activation of RIPK3 via FADD-mediated recruitment of CASP8, which cleaves RIPK1 and limits TNF-induced necroptosis (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="3 5 7 10 11 13 14 15 16 17 19 20">Interacts (via RIP homotypic interaction motif) with RIPK1 (via RIP homotypic interaction motif); this interaction induces RIPK1 phosphorylation and formation of a RIPK1-RIPK3 necrosis-inducing complex (PubMed:10339433, PubMed:11734559, PubMed:19524512, PubMed:29681455). Interacts with MLKL; the interaction is direct and triggers necroptosis (PubMed:22265413, PubMed:22421439). Interacts with ZBP1 (via RIP homotypic interaction motif); interaction with ZBP1 activates RIPK3, triggering necroptosis (By similarity). Upon TNF-induced necrosis, the RIPK1-RIPK3 dimer further interacts with PGAM5 and MLKL; the formation of this complex leads to PGAM5 phosphorylation and increase in PGAM5 phosphatase activity (PubMed:22265413, PubMed:22265414, PubMed:22421439). Binds TRAF2 and is recruited to the TNFR-1 signaling complex (PubMed:29883609). Interacts with PYGL, GLUL and GLUD1; these interactions result in activation of these metabolic enzymes (PubMed:19498109). Interacts with BIRC2/c-IAP1, BIRC3/c-IAP2 and XIAP/BIRC4 (PubMed:21931591). Interacts with ARHGEF2 (PubMed:21887730). Interacts with PELI1 (via atypical FHA domain); the phosphorylated form at Thr-182 binds preferentially to PELI1 (PubMed:29883609). Interacts with BUB1B, TRAF2 and STUB1 (PubMed:29883609).</text>
</comment>
<comment type="subunit">
<text evidence="29">(Microbial infection) Interacts (via RIP homotypic interaction motif) with herpesvirus 1 protein RIR1/ICP6 (via RIP homotypic interaction motif).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
</interactant>
<interactant intactId="EBI-514538">
<id>Q13490</id>
<label>BIRC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
</interactant>
<interactant intactId="EBI-517709">
<id>Q13489</id>
<label>BIRC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
</interactant>
<interactant intactId="EBI-1055040">
<id>Q8NB16</id>
<label>MLKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
</interactant>
<interactant intactId="EBI-358507">
<id>Q13546</id>
<label>RIPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>26</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
</interactant>
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
<label>RIPK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
</interactant>
<interactant intactId="EBI-6264672">
<id>Q9H171</id>
<label>ZBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15">Cytoplasm</location>
<location evidence="15">Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Nucleus</location>
</subcellularLocation>
<text evidence="3">Mainly cytoplasmic. Present in the nucleus in response to influenza A virus (IAV) infection.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y572-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y572-2</id>
<name>2</name>
<name>Beta</name>
<sequence type="described" ref="VSP_035106"/>
</isoform>
<isoform>
<id>Q9Y572-3</id>
<name>3</name>
<name>Gamma</name>
<sequence type="described" ref="VSP_035107"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="8">Highly expressed in the pancreas. Detected at lower levels in heart, placenta, lung and kidney.</text>
</comment>
<comment type="tissue specificity">
<molecule>Isoform 3</molecule>
<text evidence="8">Expression is significantly increased in colon and lung cancers.</text>
</comment>
<comment type="domain">
<text evidence="19">The RIP homotypic interaction motif (RHIM) mediates interaction with the RHIM motif of RIPK1. Both motifs form a hetero-amyloid serpentine fold, stabilized by hydrophobic packing and featuring an unusual Cys-Ser ladder of alternating Ser (from RIPK1) and Cys (from RIPK3).</text>
</comment>
<comment type="PTM">
<text evidence="3 7 11 12 15 20">RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation (PubMed:19524513). Autophosphorylated following interaction with ZBP1 (By similarity). Phosphorylation of Ser-199 plays a role in the necroptotic function of RIPK3 (PubMed:11734559, PubMed:19524512). Autophosphorylates at Ser-227 following activation by ZBP1: phosphorylation at these sites is a hallmark of necroptosis and is required for binding MLKL (PubMed:22265413). Phosphorylation at Thr-182 is important for its kinase activity, interaction with PELI1 and PELI1-mediated 'Lys-48'-linked polyubiquitination and for its ability to mediate TNF-induced necroptosis (PubMed:29883609).</text>
</comment>
<comment type="PTM">
<text evidence="14 20">Polyubiquitinated with 'Lys-48' and 'Lys-63'-linked chains by BIRC2/c-IAP1 and BIRC3/c-IAP2, leading to activation of NF-kappa-B (PubMed:21931591). Polyubiquitinated with 'Lys-48'-linked chains by PELI1 leading to its subsequent proteasome-dependent degradation. Ubiquitinated by STUB1 leading to its subsequent proteasome-dependent degradation (PubMed:29883609).</text>
</comment>
<comment type="similarity">
<text evidence="24">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family.</text>
</comment>
<dbReference type="EC" id="2.7.11.1" evidence="12 15"/>
<dbReference type="EMBL" id="AF156884">
<property type="protein sequence ID" value="AAD39005.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY453693">
<property type="protein sequence ID" value="AAS16359.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY494982">
<property type="protein sequence ID" value="AAS75516.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY494983">
<property type="protein sequence ID" value="AAS75517.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL096870">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK296140">
<property type="protein sequence ID" value="BAG58881.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471078">
<property type="protein sequence ID" value="EAW66021.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC062584">
<property type="protein sequence ID" value="AAH62584.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9628.1">
<molecule id="Q9Y572-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006862.2">
<molecule id="Q9Y572-1"/>
<property type="nucleotide sequence ID" value="NM_006871.3"/>
</dbReference>
<dbReference type="PDB" id="5V7Z">
<property type="method" value="NMR"/>
<property type="chains" value="A/C/E/G=448-462"/>
</dbReference>
<dbReference type="PDB" id="5ZCK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.27"/>
<property type="chains" value="A=458-461"/>
</dbReference>
<dbReference type="PDBsum" id="5V7Z"/>
<dbReference type="PDBsum" id="5ZCK"/>
<dbReference type="SMR" id="Q9Y572"/>
<dbReference type="BioGRID" id="116224">
<property type="interactions" value="39"/>
</dbReference>
<dbReference type="DIP" id="DIP-27519N"/>
<dbReference type="IntAct" id="Q9Y572">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="Q9Y572"/>
<dbReference type="STRING" id="9606.ENSP00000216274"/>
<dbReference type="BindingDB" id="Q9Y572"/>
<dbReference type="ChEMBL" id="CHEMBL1795199"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2191"/>
<dbReference type="iPTMnet" id="Q9Y572"/>
<dbReference type="PhosphoSitePlus" id="Q9Y572"/>
<dbReference type="BioMuta" id="RIPK3"/>
<dbReference type="DMDM" id="205371831"/>
<dbReference type="CPTAC" id="CPTAC-903"/>
<dbReference type="CPTAC" id="CPTAC-904"/>
<dbReference type="jPOST" id="Q9Y572"/>
<dbReference type="MassIVE" id="Q9Y572"/>
<dbReference type="PaxDb" id="Q9Y572"/>
<dbReference type="PeptideAtlas" id="Q9Y572"/>
<dbReference type="PRIDE" id="Q9Y572"/>
<dbReference type="ProteomicsDB" id="86299">
<molecule id="Q9Y572-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86300">
<molecule id="Q9Y572-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="86301">
<molecule id="Q9Y572-3"/>
</dbReference>
<dbReference type="ABCD" id="Q9Y572">
<property type="antibodies" value="2 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="9228">
<property type="antibodies" value="877 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="11035"/>
<dbReference type="Ensembl" id="ENST00000216274">
<molecule id="Q9Y572-1"/>
<property type="protein sequence ID" value="ENSP00000216274"/>
<property type="gene ID" value="ENSG00000129465"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000554756">
<molecule id="Q9Y572-3"/>
<property type="protein sequence ID" value="ENSP00000452328"/>
<property type="gene ID" value="ENSG00000129465"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000643393">
<molecule id="Q9Y572-3"/>
<property type="protein sequence ID" value="ENSP00000495915"/>
<property type="gene ID" value="ENSG00000285379"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000646516">
<molecule id="Q9Y572-1"/>
<property type="protein sequence ID" value="ENSP00000495490"/>
<property type="gene ID" value="ENSG00000285379"/>
</dbReference>
<dbReference type="GeneID" id="11035"/>
<dbReference type="KEGG" id="hsa:11035"/>
<dbReference type="UCSC" id="uc001wpb.4">
<molecule id="Q9Y572-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="11035"/>
<dbReference type="DisGeNET" id="11035"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000129465.15"/>
<dbReference type="GeneCards" id="RIPK3"/>
<dbReference type="HGNC" id="HGNC:10021">
<property type="gene designation" value="RIPK3"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000129465">
<property type="expression patterns" value="Tissue enhanced (intestine)"/>
</dbReference>
<dbReference type="MIM" id="605817">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y572"/>
<dbReference type="OpenTargets" id="ENSG00000129465"/>
<dbReference type="PharmGKB" id="PA34396"/>
<dbReference type="eggNOG" id="KOG0192">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160206"/>
<dbReference type="HOGENOM" id="CLU_559689_0_0_1"/>
<dbReference type="InParanoid" id="Q9Y572"/>
<dbReference type="KO" id="K08847"/>
<dbReference type="OMA" id="PFRNQMP"/>
<dbReference type="OrthoDB" id="769579at2759"/>
<dbReference type="PhylomeDB" id="Q9Y572"/>
<dbReference type="TreeFam" id="TF106506"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q9Y572"/>
<dbReference type="Reactome" id="R-HSA-168927">
<property type="pathway name" value="TICAM1, RIP1-mediated IKK complex recruitment"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2562578">
<property type="pathway name" value="TRIF-mediated programmed cell death"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3295583">
<property type="pathway name" value="TRP channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5213460">
<property type="pathway name" value="RIPK1-mediated regulated necrosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9013957">
<property type="pathway name" value="TLR3-mediated TICAM1-dependent programmed cell death"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937041">
<property type="pathway name" value="IKK complex recruitment mediated by RIP1"/>
</dbReference>
<dbReference type="SignaLink" id="Q9Y572"/>
<dbReference type="SIGNOR" id="Q9Y572"/>
<dbReference type="BioGRID-ORCS" id="11035">
<property type="hits" value="24 hits in 901 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RIPK3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="RIPK3"/>
<dbReference type="GenomeRNAi" id="11035"/>
<dbReference type="Pharos" id="Q9Y572">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9Y572"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 14"/>
</dbReference>
<dbReference type="RNAct" id="Q9Y572">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000129465">
<property type="expression patterns" value="Expressed in blood and 143 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9Y572">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y572">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004704">
<property type="term" value="F:NF-kappaB-inducing kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032147">
<property type="term" value="P:activation of protein kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990000">
<property type="term" value="P:amyloid fibril formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006464">
<property type="term" value="P:cellular protein modification process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097528">
<property type="term" value="P:execution phase of necroptosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048535">
<property type="term" value="P:lymph node development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070266">
<property type="term" value="P:necroptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097527">
<property type="term" value="P:necroptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001244">
<property type="term" value="P:positive regulation of intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051351">
<property type="term" value="P:positive regulation of ligase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060545">
<property type="term" value="P:positive regulation of necroptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051353">
<property type="term" value="P:positive regulation of oxidoreductase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010922">
<property type="term" value="P:positive regulation of phosphatase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000379">
<property type="term" value="P:positive regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097300">
<property type="term" value="P:programmed necrotic cell death"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046006">
<property type="term" value="P:regulation of activated T cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070235">
<property type="term" value="P:regulation of activation-induced cell death of T cells"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002819">
<property type="term" value="P:regulation of adaptive immune response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000452">
<property type="term" value="P:regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032649">
<property type="term" value="P:regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001914">
<property type="term" value="P:regulation of T cell mediated cytotoxicity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048536">
<property type="term" value="P:spleen development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033077">
<property type="term" value="P:T cell differentiation in thymus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043029">
<property type="term" value="P:T cell homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048538">
<property type="term" value="P:thymus development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR025735">
<property type="entry name" value="RHIM_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12721">
<property type="entry name" value="RHIM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-1210">Necrosis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Receptor-interacting serine/threonine-protein kinase 3" id="PRO_0000086610">
<location>
<begin position="1"/>
<end position="518"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="4">
<location>
<begin position="21"/>
<end position="287"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="4">
<location>
<begin position="27"/>
<end position="35"/>
</location>
</feature>
<feature type="short sequence motif" description="RIP homotypic interaction motif (RHIM)" evidence="19">
<location>
<begin position="450"/>
<end position="466"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="357"/>
<end position="448"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="27">
<location>
<position position="142"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="25 26 28">
<location>
<position position="50"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="164"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="20">
<location>
<position position="182"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="7 11">
<location>
<position position="199"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="15 20">
<location>
<position position="227"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="252"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="299"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="333"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="389"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="401"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="20">
<location>
<position position="363"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_035106" evidence="23">
<original>VELPTEPSLVYEAVCNRQNRPSLAELPQAGPETPGLEGLKELMQLCWSSEPKDRPSFQECLPKTDEVFQMVENNMNAAVSTVKDFLSQLRSSNRRFSIPESGQGGTEMDGFRRTIENQHSRNDVMVSEWLNKLNLEEPPSSVPKKCPSLTKRSRAQEEQVPQAWTAGTSSDSMAQPPQTPETSTFRNQMPSPTSTGTPSPGPRGNQGAERQGMNWSCRTPEPNPVTGRPLVNIYNCSGVQVGDNNYLTMQQTTALPTWGLAPSGKGRGLQHPPPVGSQEGPKDPEAWSRPQGWYNHSGK</original>
<variation>CQPNHHSCTKQCATGRTGLHWLSCPKPGLRLPA</variation>
<location>
<begin position="220"/>
<end position="518"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_035107" evidence="22 23">
<original>LPTEPSLVYEAVCNRQNRPSLAELPQAGPETPGLEGLKELMQLCWSSEPKDRPSFQECLPKTDEVFQMVENNMNAAVSTVKDFLSQLRSSNRRFSIPESGQGGTEMDGFRRTIENQHSRNDVMVSEWLNKLNLEEPPSSVPKKCPSLTKRSRAQEEQVPQAWTAGTSSDSMAQPPQTPETSTFRNQMPSPTSTGTPSPGPRGNQGAERQGMNWSCRTPEPNPVTGRPLVNIYNCSGVQVGDNNYLTMQQTTALPTWGLAPSGKGRGLQHPPPVGSQEGPKDPEAWSRPQGWYNHSGK</original>
<variation>CKTLGGFWDP</variation>
<location>
<begin position="222"/>
<end position="518"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7153640." id="VAR_051664">
<original>E</original>
<variation>V</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34106261." id="VAR_041048" evidence="9">
<original>T</original>
<variation>M</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3212254." id="VAR_041049" evidence="9">
<original>P</original>
<variation>Q</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity. Loss of PGAM5- and MLKL-binding. No effect on RIPK1-binding. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of STUB1-mediated ubiquitination." evidence="5 6 16 20">
<original>K</original>
<variation>A</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="5 6 16">
<original>K</original>
<variation>D</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity and ability to mediate necroptosis." evidence="15">
<original>D</original>
<variation>N</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of interaction with STUB1 and STUB1-mediated ubiquitination. No loss of interaction with RIPK1. Loss of ability to mediate TNF-induced necroptosis. Loss of autophosphorylation at Ser-227." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of interaction with RIPK1 and MLKL." evidence="20">
<original>T</original>
<variation>S</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with PELI1 and PELI1-mediated ubiquitination." evidence="20">
<original>Y</original>
<variation>A</variation>
<variation>F</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to mediate necroptosis. Partial loss of kinase activity. No loss of PELI1-mediated degradation." evidence="15 20">
<original>S</original>
<variation>A</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="mutagenesis site" description="No loss of PELI1-mediated degradation." evidence="20">
<original>S</original>
<variation>D</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of PELI1-mediated ubiquitination. No loss of interaction with PELI1." evidence="20">
<original>K</original>
<variation>R</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD39005." ref="1" evidence="24">
<original>G</original>
<variation>D</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD39005." ref="1" evidence="24">
<original>L</original>
<variation>P</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD39005." ref="1" evidence="24">
<original>R</original>
<variation>K</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="450"/>
<end position="461"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5V7Z"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5ZCK"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QZL0"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10339433"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10358032"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11734559"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15896315"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19498109"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19524512"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19524513"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21887730"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21931591"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22265413"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22265414"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22421439"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25316792"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29681455"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29883609"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10339433"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15896315"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<evidence key="25" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10339433"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10358032"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22265413"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22265414"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="25316792"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:10021"/>
</source>
</evidence>
<sequence length="518" mass="56887" checksum="BF755F8A0B1810A1" modified="2008-09-02" version="2">MSCVKLWPSGAPAPLVSIEELENQELVGKGGFGTVFRAQHRKWGYDVAVKIVNSKAISREVKAMASLDNEFVLRLEGVIEKVNWDQDPKPALVTKFMENGSLSGLLQSQCPRPWPLLCRLLKEVVLGMFYLHDQNPVLLHRDLKPSNVLLDPELHVKLADFGLSTFQGGSQSGTGSGEPGGTLGYLAPELFVNVNRKASTASDVYSFGILMWAVLAGREVELPTEPSLVYEAVCNRQNRPSLAELPQAGPETPGLEGLKELMQLCWSSEPKDRPSFQECLPKTDEVFQMVENNMNAAVSTVKDFLSQLRSSNRRFSIPESGQGGTEMDGFRRTIENQHSRNDVMVSEWLNKLNLEEPPSSVPKKCPSLTKRSRAQEEQVPQAWTAGTSSDSMAQPPQTPETSTFRNQMPSPTSTGTPSPGPRGNQGAERQGMNWSCRTPEPNPVTGRPLVNIYNCSGVQVGDNNYLTMQQTTALPTWGLAPSGKGRGLQHPPPVGSQEGPKDPEAWSRPQGWYNHSGK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

